Andrea Chicca

Overview

Gender
male

Andrea holds a PhD in Pharmacology from the University of Pisa. After his first post-doctoral studies in cancer biology at the Istituto Toscano Tumori (Firenze, Italy), Andrea joined the group of Prof. J. Gertsch at the University of Bern initially working as post-doctoral scientist, then senior scientist and principal investigator.

​In November 2018, Andrea obtained the venia docendi in Biochemistry and Molecular Medicine awarded from the Medical Faculty of the University of Bern. In December 2018, he obtained also the habilitation for professorship in Pharmacology from the Italian Ministry of Education and Research. Andrea is co-author of 45+ scientific articles published in international peer-reviewed journals.


​He strongly contributed to the elucidation of the endocannabinoid membrane transport mechanism and the development of SERIs of first and second generation. Andrea is co-inventor on a granted patent covering SERIs of first generation in the US.


Before joining the University of Bern, Andrea worked for almost 2 years as a scientific advisor in the corporate marketing of Chiesi Pharmaceuticals (Parma, Italy), where he acquired hands-on experience in preclinical and clinical drug development.

Jobs

Number of Current Jobs
1
Andrea Chicca has 1 current jobs including Co-Founder, Chief Executive Officer and Chief Scientific Officer at Synendos Therapeutics , .
Organization Name Title At Company Start Date End Date
Synendos Therapeutics Co-Founder, Chief Executive Officer and Chief Scientific Officer Apr 1, 2019 Detail